AbbVie Inc v. Amgen Inc
AbbVie Inc v. Amgen Inc is a federal patent lawsuit filed on 08/04/2016 in the District Court, D. Delaware. The case was terminated on 09/28/2017.
- Court
- District Court, D. Delaware (D. Del.)
Official Court Website → - Assigned judge
- Mitchell S. Goldberg · 282 cases in index
- Docket number
- 1:16-cv-00666
- Cause
- 35:271 Patent Infringement
35 U.S.C. § 271 — Patent infringement - Nature of suit
- 830 Patent
Infringement of a patented invention. - Jurisdiction
- Federal Question
- Jury demand
- None
- Date filed
- 08/04/2016
- Date terminated
- 09/28/2017
11,768 Patent cases in this court are indexed here.
Parties
- plaintiff · AbbVie Inc Pharmaceuticals & Biotechnology · 5032 cases
- defendant · Amgen Inc Pharmaceuticals & Biotechnology · 229 cases
Part of a Larger Litigation Pattern
This is one of 230 Patent cases in our index naming AMGEN INC — a possible mass-tort or coordinated-litigation cluster.
About Patent Lawsuits
Patent lawsuits allege infringement of a patented invention — that another party made, used, or sold a protected technology without authorization. These cases are common in technology and pharmaceutical industries.
Frequently Asked Questions
What is AbbVie Inc v. Amgen Inc?
AbbVie Inc v. Amgen Inc is a federal patent lawsuit filed on 08/04/2016 in the District Court, D. Delaware. The case was terminated on 09/28/2017. Patent lawsuits allege infringement of a patented invention — that another party made, used, or sold a protected technology without authorization. These cases are common in technology and pharmaceutical industries.
What type of case is this?
It is classified as “Patent” under the federal nature-of-suit system. Patent lawsuits allege infringement of a patented invention — that another party made, used, or sold a protected technology without authorization. These cases are common in technology and pharmaceutical industries.
What court is the case in?
The case is in the District Court, D. Delaware, docket number 1:16-cv-00666.
When was the case filed?
AbbVie Inc v. Amgen Inc was filed on 08/04/2016. It was terminated on 09/28/2017.
What law is the case brought under?
The docket lists the cause as 35 U.S.C. § 271 — Patent infringement.
Other Cases Involving These Parties
Related Patent Cases
Source: public U.S. federal court record (docket 4221181).